Advertisement
ACB vs CPIX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a StrongBuy and CPIX is a Hold.
ACB's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ACB turned positive on November 03, 2026. Looking at past instances where ACB's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on ACB as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
ACB moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ACB crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +24.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACB advanced for three days, in 180 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 79 of 116 cases where ACB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
ACB broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.629) is normal, around the industry mean (6.379). P/E Ratio (-2.701) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.984) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ACB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
CPIX sees its Stochastic Oscillator ascends from oversold territory
On November 09, 2026, the Stochastic Oscillator for CPIX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 65 instances where the indicator left the oversold zone. In 60 of the 65 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CPIX's RSI Oscillator exited the oversold zone, 17 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CPIX as a result. In 94 of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
Following a +7.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPIX advanced for three days, in 176 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
CPIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CPIX turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 50 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
CPIX moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CPIX crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for CPIX entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CPIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.485) is normal, around the industry mean (6.379). P/E Ratio (-7.151) is within average values for comparable stocks, (0.548). CPIX's Projected Growth (PEG Ratio) (17.640) is very high in comparison to the industry average of (2.202). CPIX's Dividend Yield (1.149) is considerably higher than the industry average of (0.062). P/S Ratio (2.362) is also within normal values, averaging (183.387).
The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ACB | CPIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 57 | |
SMR RATING 1..100 | 96 | 98 | |
PRICE GROWTH RATING 1..100 | 36 | 39 | |
P/E GROWTH RATING 1..100 | 98 | 15 | |
SEASONALITY SCORE 1..100 | 32 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACB's Valuation (24) in the Pharmaceuticals Other industry is in the same range as CPIX (51). This means that ACB’s stock grew similarly to CPIX’s over the last 12 months.
CPIX's Profit vs Risk Rating (57) in the Pharmaceuticals Other industry is somewhat better than the same rating for ACB (100). This means that CPIX’s stock grew somewhat faster than ACB’s over the last 12 months.
ACB's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as CPIX (98). This means that ACB’s stock grew similarly to CPIX’s over the last 12 months.
ACB's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as CPIX (39). This means that ACB’s stock grew similarly to CPIX’s over the last 12 months.
CPIX's P/E Growth Rating (15) in the Pharmaceuticals Other industry is significantly better than the same rating for ACB (98). This means that CPIX’s stock grew significantly faster than ACB’s over the last 12 months.
| ACB | CPIX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 84% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 79% | 2 days ago 84% |
| Advances ODDS (%) | 8 days ago 77% | 3 days ago 83% |
| Declines ODDS (%) | 2 days ago 84% | 14 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACB’s FA Score shows that 1 FA rating(s) are green while CPIX’s FA Score has 1 green FA rating(s).
- ACB’s FA Score: 1 green, 4 red.
- CPIX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACB’s TA Score shows that 6 TA indicator(s) are bullish while CPIX’s TA Score has 5 bullish TA indicator(s).
- ACB’s TA Score: 6 bullish, 4 bearish.
- CPIX’s TA Score: 5 bullish, 5 bearish.
Price Growth
ACB (@Pharmaceuticals: Generic) experienced а -0.97% price change this week, while CPIX (@Pharmaceuticals: Generic) price change was +22.97% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
ACB is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
ACB and
Correlation & Price change
A.I.dvisor indicates that over the last year, ACB has been closely correlated with CGC. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACB jumps, then CGC could also see price increases.
| Ticker / NAME | Correlation To ACB | 1D Price Change % | ||
|---|---|---|---|---|
| ACB | 100% | -0.97% | ||
| CGC - ACB | 69% Closely correlated | -4.88% | ||
| SNDL - ACB | 65% Loosely correlated | -0.71% | ||
| TLRY - ACB | 63% Loosely correlated | -7.02% | ||
| TRLV - ACB | 58% Loosely correlated | +0.73% | ||
| OGI - ACB | 55% Loosely correlated | -2.69% | ||
More | ||||
CPIX and
Correlation & Price change
A.I.dvisor tells us that CPIX and ACB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and ACB's prices will move in lockstep.
| Ticker / NAME | Correlation To CPIX | 1D Price Change % | ||
|---|---|---|---|---|
| CPIX | 100% | -1.30% | ||
| ACB - CPIX | 27% Poorly correlated | -0.97% | ||
| QNTM - CPIX | 26% Poorly correlated | -9.42% | ||
| GLAS - CPIX | 23% Poorly correlated | +2.60% | ||
| YCBD - CPIX | 23% Poorly correlated | +0.71% | ||
| PRGO - CPIX | 22% Poorly correlated | -0.71% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TDEC | 26.23 | -0.04 | -0.14% |
| FT Vest Emerging Markets Buffer ETF - December (TDEC) | |||
| XTN | 102.97 | -0.31 | -0.30% |
| State Street SPDR S&P Transportation ETF (XTN) | |||
| PBOC | 31.30 | -0.09 | -0.30% |
| PGIM S&P 500 Buffer 20 ETF - October (PBOC) | |||
| BIV | 73.90 | -0.52 | -0.70% |
| Vanguard Intermediate-Term Bond ETF (BIV) | |||
| PHK | 4.15 | -0.04 | -0.95% |
| PIMCO High Income Fund | |||